Skip to content
NBDC Human Database

No datasets in the cart.

Go to the cart

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Research ID

hum0575-v1Release info

Latest

Research title

Comprehensive gene expression analysis in renal cell carcinoma

Research overview

Aims
The goal is to elucidate the mechanisms of tumor initiation and progression, identify gene signatures associated with drug efficacy and adverse effects, and develop more accurate and reliable diagnostic methods and therapeutic targets.
Methods
RNA extracted from frozen tissue sections obtained from tumor and normal renal cortex specimens was used for RNA-seq analysis.
Participants/materials
201 patients diagnosed with renal cell carcinoma
URL
N/A

Datasets

CartDataset IDType of dataAnalysis methodAccess criteriaDate published
JGAD001057NGS (RNA-seq)
  • RNA-seq
Controlled-access (Type I)2026-07-16

Data provider

Principal investigator
Renpei Kato
Affiliation
Department of Urology, Iwate Medical University

Research projects

NameURL
Comprehensive Genomic Exploration Study in Renal Cell Carcinoma
N/A

Grants

NameTitleProject number
Moonshot R&D Program, Japan Science and Technology Agency (JST)
Challenge toward the Control of Intractable Cancer through Understanding of Molecular, Cellular, and Interorgan Networks
  • JPMJMS2022
Practical Research for Innovative Cancer Control, Japan Agency for Medical Research and Development (AMED)
First-in-human phase I study of a tumor suppressor-activating therapeutic peptide
  • JP25ck0106888

Related publications

No related publications.

Controlled access users

No use of the controlled access data has been recorded.